Stada Grabs Six OTC Brands From GSK
Stada has acquired a portfolio of six OTC brands from GSK that will expand its Consumer Health business in Europe as well as selected APAC and Latin American markets.
You may also be interested in...
After a 12-month period that has seen Stada make significant investments in generics, biosimilars and consumer healthcare, CEO Peter Goldschmidt tells Generics Bulletin that the firm does not intend to stop there, as it pursues both organic and inorganic growth opportunities.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.
Stada has added to its consumer healthcare business in the Philippines by acquiring the Fern C range of vitamin C food supplements.